Recruiting Dry Eye Studies in Lynchburg
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED) compared to healthy vo...
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye....
About Dry Eye Clinical Trials in Lynchburg
Dry eye disease is a common condition that occurs when tears are unable to provide adequate lubrication for the eyes. It affects millions of people and can cause discomfort and vision problems. Treatment includes artificial tears, prescription eye drops, and procedures to conserve tears.
There are currently 2 dry eye clinical trials recruiting participants in Lynchburg, VIRGINIA. These studies are seeking a combined 510 participants. Research is being sponsored by Hoffmann-La Roche, Vanda Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Dry Eye Clinical Trials in Lynchburg — FAQ
Are there dry eye clinical trials in Lynchburg?
Yes, there are 2 dry eye clinical trials currently recruiting in Lynchburg, VIRGINIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lynchburg?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lynchburg research site will contact you about next steps.
Are clinical trials in Lynchburg free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lynchburg studies also compensate for your time and travel.
What dry eye treatments are being tested?
The 2 active trials in Lynchburg are testing new therapies including novel drugs, biologics, and treatment approaches for dry eye.
Data updated March 2, 2026 from ClinicalTrials.gov